Lightcalls.com
 

FACTS cash ACONCENTRUEDEFFORT Wa...

FACTS cash

ACONCENTRUEDEFFORT

Want to become wealthy? avow a business.

That looks to be the way the majority of high-net-worth (HW) individuals have attained their wealth. In fact, a scan conducted by The Stenner cluster and CV Marketing Research last October construct some 51.4% of HNW individuals in the Greater Vancouver area had accumulated their wealth by means of owning a business or professional practice. That's a beautiful convincing argument for the benefits of business ownership.

Want to stay wealthy? Well, then you might want to do the opposite.

This is the great irony of owning a business: As a business becomes more lucky the greater the risk it instants to its owner. Simply propose by holding the bulk of their pure worth within a single asset, possessors take a big gamble with their financial well-being. To eliminate the risk of over-concentration, possessors need to release equity from the same business that made them wealthy in the first place.

Thankfully, BC's CAs and other financial professionals are forward hand to help. By highlighting the dangers of over-concentrated positions and suggesting appropriate strategies to minimize concentration risk, professionals are steering HNW clients toward a more balanced allocation of wealth.



A pressing issue

"[Concentration risk] is a significant issue for business proprietors absolutely," says Kelly Rich, CA, a partner with Johnsen Archer in Surrey

But Riehl argues that this is no other than one side of the issue. "It isn't like an employee" she says. "[For business owners] their assets are tied up and their ability to generate income is tied up"

With with equal reason much at stake, over-concentration is an issue proprietors need to take seriously. if it be not that do owners share this concern?

Melanie irritates CA, a partner with Meyer Frer & Co in Burnaby, thinks they do: "A fortune of owner/managers realize they have a portion tied up in their businesses."

But Frer calculators that awareness doesn't necessarily mean action. In fact, holders may be dead set against the idea of putting their currency anywhere but into the business they curb

"Some business owners will take a big risk in investing in their business when they wouldn't elsewhere, because they know their business," she explains. "They don't diocese where they can invest elsewhere."

Gordon Caulder, CA, a partner with Lohn Caulder in Vancouver, agrees that over-concentration is a public problem among successful business proprietors "Successful ones have too a great deal of money in their operating companies-no question," he states emphatically.

From his perspective, taking any of that money off the table is nothing more than for the use of all sense put into practice: "You have to secure what you've managed to accumulate."

Simple in theory; tangle in reality

Easier said than done. To chiefly professionals, the issue of diversification is cross and dried: From a security perspective, it's a dutiful idea to keep a client's ovums in more than one basket. In reality, however, the issue is rarely in like manner simple.

"When you outline the question at issue it's perfectly logical," says Riehl." unless when you're dealing with owner/managers, a hazard of the issues you approach in a clinical way, they approach in an emotional way. They're more tied up in their business than the professional is because the issues are earnestly closer to home."

As Riehl points on the outside professionals tend to see the business as an investment, whereas proprietors usually see it as something more. Riehl believes professionals ne to relate to this difference in viewpoint, and anticipate more [i]or[/i] less of the complex emotions clients may face when the make submissive of diversification comes up. by what mode does one do that? Riehl advises professionals to "move away from a exquisitely clinical approach into something that's more balanced."

Her approach highlights another issue professionals have to face when advising a client to release equity from a business. While professionals have a toll to be the "voice of reason" when advising clients, they must avoid coming across as discouraging or inhibitive. annoys puts the point plainly: "You have to be really careful there. If a client is surpassingly excited about doing something in their business, and you advance off negatively about it, the client is going to make progress somewhere else." Frets describes it as a fine balance--one that requires careful communication and well-developed negotiation skills.

These skills reach [i]or[/i] attain any place [i]or[/i] point in handy when dealing with what is perhaps the principally difficult aspect of business ownership: the family (see Beyond Numbers, November 2002 page 18) As Caulder explains it, family oftentimes adds another layer of complexity to the issue of concentration risk. When holders want to release equity from a business on the other hand other family members do not, the potential for question at issues is high.

"Strife, conflict, anguish, emotion-it's all there," he says matter-of-factly.

Managing these mixed issues requires a deft hand. In a certain number of cases, professionals may have to sacrifice an otherwise viable financial solution for the profitable of the client relationship. "[Professionals] have to balance what we think is righteous for our clients' long-term health with what's worthy for the short-term relationship," says Caulder.



Other Articles
 -Morphotek will collaborat...
 -Eksigent Technologies nam...
 -The benefits of outsourci...
 -Sartorius Corporation ...
 -In our previous column, w...
 -Efoora appointed Michael ...
 -Affymax appointed Anne-Ma...
 -Traditionally, continuous...
 -New Brunswick Scientific ...
 -The German-American firm ...
 -Don G. Burstyn, formerly ...
 -American patients are mor...
 -Summary Prior to va...
 -BioPharm Editorial Adviso...
 -Australia agreed to spend...
 -The Biotechnology Industr...
 -Ambion, The RNA Company i...
 -Therapies based on living...
 -A recent survey found tha...
 -ViroLogic will acquire Ac...
 -Cardinal Health named Joh...
 -One of the greatest chall...
 -As the president of a sma...
 -Sweden-based Biovitrum wi...
 -Nanogen appointed David L...
 -The Experion Process Know...
 -Although biomedical resea...
 -The Supreme Court of Cana...
 -Netherlands-based DSM Bio...
 -David A. Smoller joined S...
 -A few months ago, I wrote...
 -Panacos Pharmaceuticals w...
 -Karen K. Vaccaro will res...
 -Acceleron Pharma appointe...
 -Two quarterly meetings of...
 -Illinois-based Abbot Labo...
 -FKI Logistics announced t...
 -The following corrections...
 -It its widest definition,...
 -UK-based Xcellsyz will li...
 -Andrew P. Aromando joined...
 -Invitrogen's comprehensiv...
 -Last month, we described ...
 -The Swiss life sciences c...
 -Protein Design Labs (PDL)...
 -Model It HNMR, the newest...
 -Tech transfer, like chang...
 -QLT and Atrix Laboratorie...
 -Dendreon announced Christ...
 -Baxter Pharmaceutical Sol...
 -The biopharmaceutical ind...
 -GlaxoSmithKline announced...
 -Montreal-based Caprion Ph...
 -Xenova Group recently ann...
 -Cole-Parmer's new 192-pag...
 -Over the last decade ther...
 -Benchmark your facility p...
 -As biotechnology organiza...
 -Frederick D. Sancillo, fo...
 -Insmed acquired a recombi...
 -Baxter Pharmaceutical Sol...
 -Model It HNMR, the newest...
 -DA's regulation 21 CFR Pa...
 -Robert P. Ryan joined Ath...
 -A new report from Busines...
 -Biotest offers a complete...
 -Swagelok offers a brochur...
 -Partnering is a global ph...
 -Human Genome Sciences CEO...
 -Shorten the process devel...
 -The licensure of biotechn...
 -Rodger Currie joined Amge...
 -The GEA Filtration Model ...
 -A multi-channel chemistry...
 -From June 6-9, San Franci...
 -Skanska USA Building Inc....
 -New Brunswick Scientific'...
 -AVI BioPharma appointed P...
 -Ambion, The RNA Company, ...
 -"If you want to be a...
 -Xcellerex appointed Susan...
 -Researchers identified th...
 -Cool Spring Business Park...
 -In October 2003, Shenzhen...
 -Laureate Pharma appointed...
 -After a 6-5 vote by Calif...
 -QSourcing, a service of Q...
 -The recent discovery of &...
 -Affymax added Douglas L. ...
 -USDA recently approved tw...
 -BioPharm International is...
 -Serologicals has released...
 -This document by Shenzhen...
 -Robert Bronstein joined A...
 -Gloucester Gains Fujisawa...
 -With more than 30 years o...
 -Pall's SUPRAdisc II depth...
 -In today's competitive ma...
 -Protein Design Labs repor...
 -Charles A. Rice will repl...
 -AstraZeneca's Faslodex (f...
.
© 2006 Lightcalls.com All rights reserved.